Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.42B | 29.09B | 22.81B | 16.36B | 13.11B |
Gross Profit | 4.41B | 4.66B | 3.85B | 3.14B | 2.36B |
EBITDA | 1.70B | 1.94B | 1.54B | 1.50B | 1.05B |
Net Income | 975.20M | 1.09B | 2.95B | 881.99M | 1.82B |
Balance Sheet | |||||
Total Assets | 29.33B | 33.15B | 28.93B | 18.07B | 14.97B |
Cash, Cash Equivalents and Short-Term Investments | 3.11B | 3.10B | 3.87B | 3.27B | 2.97B |
Total Debt | 13.41B | 17.22B | 14.63B | 6.36B | 4.99B |
Total Liabilities | 18.34B | 22.75B | 19.45B | 11.47B | 9.21B |
Stockholders Equity | 10.98B | 10.32B | 9.41B | 6.54B | 5.70B |
Cash Flow | |||||
Free Cash Flow | 4.22B | -3.09B | -3.98B | 34.20M | 903.50M |
Operating Cash Flow | 4.30B | -3.04B | -3.86B | 58.09M | 945.47M |
Investing Cash Flow | -61.84M | 58.59M | 1.03B | -20.13M | 1.90B |
Financing Cash Flow | -4.22B | 2.28B | 3.35B | 213.98M | -945.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥6.77B | 6.57 | 2.00% | 17.83% | 44.85% | ||
79 Outperform | ¥6.63B | 9.35 | 2.94% | 10.36% | 18.42% | ||
76 Outperform | ¥6.22B | 6.11 | 2.77% | 0.62% | -9.58% | ||
71 Outperform | ¥5.91B | 7.04 | 3.71% | 17.34% | 71.26% | ||
66 Neutral | ¥8.17B | 27.06 | ― | 341.55% | -0.36% | ||
53 Neutral | $1.24B | 2.72 | -2.60% | 5.66% | -2.15% | -149.23% | |
48 Neutral | ¥6.15B | 86.88 | 0.29% | 65.02% | ― |